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The increasingly high-profile prion
protein is involved in a class of
devastating neurological diseases,
including human Creutzfeld–Jakob
disease, scrapie in sheep and goats,
and ‘mad cow disease’. It is highly
conserved among mammalian
species, is found on the surface of
cells that produce it, and is expressed
in many tissues, including the brain.
Like the superhero Batman, the
prion protein may lead a double life.
Just as one must get to know
Batman’s alter ego — mild-mannered
Gotham City millionaire Bruce
Wayne — to understand the caped
crusader, understanding the role of
the prion protein in disease may
require an appreciation of the
function of its seemingly innocuous
cellular form.
An infectious protein?
Scrapie is a neurodegenerative
disease of sheep which is charac-
terized by spongiform degeneration of
the brain and the accumulation of a
fibrillar protein aggregate in the brain.
(Mad cow disease, or bovine
spongiform encephalopathy (BSE) is
the analogous disease in cattle.)
Carleton Gadjusek demonstrated
more than thirty years ago, in work for
which he was awarded the 1976
Nobel Prize, that scrapie could be
transmitted from one animal to
another via intracerebral injection of a
homogenate of infected brain tissue.
Gadjusek called the infectious agent a
‘slow-virus’, but unlike any known
virus, no specific nucleic acid
component of the infectious agent has
been detected. In response to this
paradox, J.S. Griffith postulated in
1967 that the agent contained only
protein (the ‘protein-only’
hypothesis), and suggested several
possible mechanisms by which such
an entity could self-replicate. 
In the early 1980s, a single protein
was identified as the major
component both of the scrapie-
associated fibrils in diseased brain and
of brain preparations enriched in
scrapie infectivity. Surprisingly, the
amino-acid sequence of this disease-
associated protein seems to be
identical to that of a normal cellular
protein. Also in the early 1980s,
Stanley Prusiner coined the name
‘prion’ (protein infectious virion) to
reflect his belief that the disease-
associated protein — designated the
prion protein scrapie-associated form,
or PrPSc — was the one to which
Griffith’s hypothesis referred. The
normal cellular form of the protein is
designated PrPC.
The idea that a disease-associated
protein can in some way recruit a
normal cellular protein to become
disease-causing is contrary to much
of conventional thinking about
disease-causing agents; the idea has
yet to be universally accepted, not
least because a number of aspects of
the transmission of related
spongiform encephalopathies remain
to be understood (see box). For
example, it seems that both BSE and
scrapie can be transmitted to other
The pressing public health issues
concerning prions involve disease
transmission, especially the possibility that
BSE is transmitted from cattle to humans;
there is some evidence that eating BSE-
infected beef might be responsible for the
emergence of a new strain of
Creutzfeldt–Jakob disease in humans.
Some critical questions about prion
transmission, and speculations on the
answers, are as follows.
How are prion diseases transmitted
from one individual to another?
It is not at all clear how, for example,
scrapie is passed from one sheep to
another. There are examples of spongiform
encephalopathies that seem to be passed
on by eating infectious tissue — for
example, BSE in cattle is thought to result
from their being fed infectious material,
and kuru, a human disease, is thought to
be passed on by cannibalistic ritual. In
addition, there is some evidence that
scrapie can be passed on to animals by
others in their herd or group, and perhaps
even by contact with the same food or
bedding material as infected animals. 
How did the original PrPSc arise, and is
it possible to contract a prion disease
without being infected or inheriting a
mutant form of PrP?
It is possible that there is a very low
spontaneous rate of conversion from the
normal cellular form to the ‘scrapie’ form of
the protein. If the disease-associated form
is capable of self-replication (see text and
Fig. 1), a small amount of ‘seed’ would be
necessary for conversion of PrPC to PrPSc.
And if the disease-associated form is
infectious, once it has replicated in one
individual it might be able to pass to
another. In addition, very rare mutations
might convert the normal prion protein to a
disease-associated form that aggregates
or is transmitted more readily.
Can mutations in the PrP gene cause
inherited diseases?
There are inherited spongiform
encephalopathies that may be attributable
to mutant forms of the PrP protein. How
this causes disease is not yet clear.
If the infectious agent is an ordered
polymer of PrPSc, how can it get into the
brain, across the blood–brain barrier?
This remains a mystery, but several lines of
evidence suggest that the lymph nodes
provide a way-station en route to the
brain. Perhaps the agent is taken up by
nerve terminals and travels retrogradely up
to the central nervous system.
How can we test the likelihood of
bovine–human transmission?
Studies with laboratory animals, such as
mice and hamsters, have already provided
a lot of information on the behaviour of
PrP. Perhaps similar studies using rodents
as well as primates will, together with
increasing amounts of epidemiological
evidence, provide new insights.
Can the PrPC–PrPSc conversion be
inhibited?
A number of strategies based on perturbing
the presumed folding intermediates are
being actively investigated.
How are prion protein diseases transmitted?
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animals, such as mice or hamsters,
but the transmitted disease retains
some characteristics of either BSE or
scrapie in the recipient animal. How
is this possible if both diseases rely
on the same single cellular protein
for their perpetuation? Even ‘strain-
specific’ characteristics of a single
disease, such as how long it takes to
develop and precisely which parts of
the brain it affects, are transmitted
with the infectious agent. Again, it is
hard to see how a single protein can
achieve this.
In this article, we will consider a
model for the behavior of the normal
and disease-associated prion
proteins, and the extent to which this
model explains what we know about
transmissible spongiform
encephalopathies. We will refer to
the infectious entity as ‘the agent’
rather than the prion, in order to
avoid confusing it with PrPSc, as the
protein-only hypothesis has yet to be
proven definitively, for example by a
demonstration that PrPSc produced in
vitro is infectious.
Infection by a protein-only agent
The normal, cellular form of the
prion protein is not infectious. It is
expressed in many tissues and by
many cell types but has no known
function. Mice lacking the PrP gene,
first produced by Charles Weissmann
and colleagues, are viable, but have
altered neuronal function and
develop neurological abnormalities
later in life. Strikingly, these ‘PrP
knockout’ mice are resistant to
infection by the scrapie agent. 
The failure to detect covalent
chemical differences between the
scrapie-associated PrPSc and the
normal PrPC led James Hope to
suggest that they might be
conformational isomers of one
another, an idea originally postulated
by Griffith and recently supported by
spectroscopic studies. According to
the protein-only hypothesis,
infectious PrPSc in an innoculum must
be able to convert host PrPC into
additional copies of PrPSc, thus
replicating itself. We and our
colleagues have demonstrated that
this conversion can take place outside
the cell, in a system containing only
PrPSc isolated from infected brain and
PrPC produced in cell culture. The
conversion in vitro is most effective
when the PrPC and PrPSc used in the
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A proposal to explain the involvement of PrPC and PrPSc in the replication of
PrPSc. The tendency of the prion protein to aggregate may be important in
its normal funciton (a), as well as its disease-associated behavior (b). (a)
The normal function of PrPC, which is anchored to the cell surface by a
glycosyl-phosphatidyl inositol (GPI) tail, is unclear, but might involve
controlled two-dimensional oligomerization in the plane of the membrane.
The functional form of PrPC may be a monomer, but could also be a dimer
(as shown), or a higher oligomer. The oligomeric forms could be stabilized
and prevented from proceeding to a PrPSc nucleus by attachment to the
membrane and/or specific interactions with another cell-surface molecule.
Nucleation of PrPSc would not occur in a cellular compartment either,
provided that the PrPC concentration was kept below the ‘critical
concentration’. (b) In scrapie, PrPSc replication could be initiated by an
interaction between an extracellular PrPSc seed with any form of cell-
surface PrPC (the dimer is shown). This interaction could inhibit the normal
function of PrPC and seed its ordered polymerization, producing more PrPSc
at the cell surface (provided that the inhibitory factors postulated in (a)
could be circumvented), or, after internalization, in a cellular compartment
(provided that the concentration of PrPC in the compartment exceeded the
thermodynamic solubility of PrPSc). Accumulation of PrPSc could block
normal degradative and/or recycling pathways and lead to progressive
neuronal dysfunction.
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assay are derived from the same
species, and it can propagate the
biochemical properties associated with
specific disease strains. These results
suggest that other endogenous factors
are not required for the conversion to
occur, although such factors may
normally be involved in vivo.
The conversion of PrPC to PrPSc
in vitro could take place by means of
nucleated polymerization, with PrPSc
acting as a seed which induces
polymerization of PrPC, or via the
formation of a heterodimer
containing one monomer of PrpSc and
one of PrPC. Mechanistic studies of
the conversion in vitro strongly
support the nucleated polymerization
model; we believe that PrPSc is a
polymeric seed which replicates itself
by inducing PrPC to polymerize in
vivo and produce additional PrPSc, as
outlined in Figure 1. For the
purposes of the discussion below, we
define a polymer to be a
heterogeneous collection of
multimers, each capable of growth. In
contrast, an oligomer is a defined
multimeric species which is not
capable of further polymerization.
Neurodegeneration
Mice lacking the PrP gene can
develop progressive coordination
problems (as do scrapie-infected
sheep and BSE-infected cattle).
Thus, PrPSc-induced neuro-
degeneration may be partly due to
loss of normal PrPC function (the
effect might be indirect, for example,
if PrPC affects neural development in
a manner which becomes evident
only in aged animals). Neuro-
degeneration in infectious scrapie is
clearly more rapid than that observed
in the PrP knockout mice, however,
arguing that PrPSc itself is neurotoxic. 
Adriano Aguzzi and Charles
Weissmann have examined the roles
of PrPSc and PrPC in neuronal degen-
eration by grafting brain tissue from
transgenic mice which overexpress
PrPC (5–8-fold higher levels than in
wild-type mice) into the brain of an
otherwise identical mouse lacking the
PrP gene. After inoculation with
PrPSc, the graft underwent rapid
spongiform degeneration but no
degeneration of the adjacent tissue
lacking PrPC was observed, despite
the fact that this tissue contained an
amount of PrPSc easily sufficient to
transmit the disease. This result
suggests that both cell-surface PrPC
and extracellular PrPSc are required
for neurodegeneration to occur; PrPSc
may be a pathogenic ligand for PrPC
(see Fig. 1). This model does not
explain why degeneration is appar-
ently specific to the brain even
though PrPC expression is wide-
spread. The answer to this question
may involve the role played by PrPC
in the unique biology of the neuron.
Function of the cellular prion protein
The function of the cellular prion
protein PrPC, which is anchored to
the cell-surface by a glycolipid
attachment, is unknown. Its
sequence is highly conserved, which
usually implies that a protein has
some important function. But the
mild phenotype observed in some
PrP knockout mice — reduced long-
term potentiation of synaptic
transmission, which is normally
associated with learning, and sleep
pattern abnormalities — suggests
that whatever the normal role of
PrPC, it can be at least partially
fulfilled by other proteins. 
Point mutations in the PrP gene
can lead to inherited human
neurological diseases which resemble
transmissible scrapie, such as
Creutzfeldt–Jakob disease,
Gerstmann–Straussler–Scheinker
disease and fatal familial insomnia. It
is difficult to understand why a gene
sequence that is only a single
mutation away from protein
aggregation and neurological disaster
should be conserved. We propose a
solution to this paradox. The normal
function of PrPC may require its
controlled oligomerization under
conditions which prevent the
uncontrolled polymerization that
would lead to PrPSc formation. The
oligomerized normal protein could
be involved in cell–cell interactions,
synapse formation or membrane
protein recycling. The elucidation of
this normal function could hold the
key to understanding the
pathogenesis of scrapie and related
spongiform encephalopathies.
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